مقالات بحثية تمّ التفويض بإتاحتها للجميع - Taofeek K. Owonikoko, MD/PhDمزيد من المعلومات
عدد المقالات البحثية غير المتاحة للجميع في أي موقع: 8
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment
P Shi, YT Oh, G Zhang, W Yao, P Yue, Y Li, R Kanteti, J Riehm, R Salgia, ...
Cancer letters 380 (2), 494-504, 2016
التفويضات: US National Institutes of Health
Telaglenastat plus cabozantinib or everolimus for advanced or metastatic renal cell carcinoma: an open-label phase I trial
F Meric-Bernstam, NM Tannir, O Iliopoulos, RJ Lee, ML Telli, AC Fan, ...
Clinical Cancer Research 28 (8), 1540-1548, 2022
التفويضات: US National Institutes of Health
BRD4 levels determine the response of human lung cancer cells to BET degraders that potently induce apoptosis through suppression of Mcl-1
D Zong, J Gu, GC Cavalcante, W Yao, G Zhang, S Wang, TK Owonikoko, ...
Cancer Research 80 (11), 2380-2393, 2020
التفويضات: National Natural Science Foundation of China
Survival outcomes with thoracic radiotherapy in extensive-stage small-cell lung cancer: a propensity score-matched analysis of the national cancer database
S Tian, X Zhang, R Jiang, RN Pillai, TK Owonikoko, CE Steuer, NF Saba, ...
Clinical Lung Cancer 20 (6), 484-493. e6, 2019
التفويضات: US National Institutes of Health
Adenosquamous carcinoma of the esophagus: an NCDB-based investigation on comparative features and overall survival in a rare tumor
M Evans, Y Liu, C Chen, C Steuer, R Cassidy III, J Landry, K Higgins, ...
Oncology 93 (5), 336-342, 2017
التفويضات: US National Institutes of Health
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non–Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and …
B El Osta, J Carlisle, C Steuer, S Pakkala, T Leal, M Dhodapkar, Y Liu, ...
Clinical Lung Cancer 23 (7), e400-e404, 2022
التفويضات: US National Institutes of Health
Lung cancer in the elderly: what's age got to do with it?
TK Owonikoko, SS Ramalingam, FR Khuri
Oncology 24 (12), 1120, 2010
التفويضات: US National Institutes of Health
KontRASt-02: A Phase III Trial Investigating the Efficacy and Safety of the KRASG12C Inhibitor JDQ443 vs. Docetaxel in Patients with Previously Treated, Locally Advanced or …
F Cappuzzo, G Castro, JH Kang, YL Wu, OT Brustugun, PK Cheema, ...
International Journal of Radiation Oncology, Biology, Physics 118 (1), e14, 2024
التفويضات: US National Institutes of Health
عدد المقالات البحثية المتاحة للجميع في موقع ما: 197
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
التفويضات: US Department of Defense, US National Institutes of Health
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
التفويضات: US Department of Defense, US National Institutes of Health
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
التفويضات: US National Institutes of Health, Cancer Research UK
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
التفويضات: US National Institutes of Health
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
التفويضات: US National Institutes of Health
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
التفويضات: US National Institutes of Health
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
التفويضات: US National Institutes of Health
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
التفويضات: US National Institutes of Health, US Department of Veterans Affairs …
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
التفويضات: US Department of Defense, US National Institutes of Health
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
AO Kamphorst, A Wieland, T Nasti, S Yang, R Zhang, DL Barber, ...
Science 355 (6332), 1423-1427, 2017
التفويضات: US National Institutes of Health
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
التفويضات: US National Institutes of Health
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
التفويضات: US National Science Foundation, US National Institutes of Health
يتم تحديد معلومات التمويل والنشر من خلال برنامج كمبيوتر تلقائيًا.